{ "cik": 12208, "cik_padded": "0000012208", "entityName": "BIO-RAD LABORATORIES, INC.", "fiscal_years": [ { "accn": "0000012208-26-000010", "filed": "2026-02-13", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 295500000.0, "capex": 157600000.0, "cash": 529800000.0, "cost_of_revenue": 1243300000.0, "eps_diluted": 27.85, "free_cash_flow": 374600000.0, "gross_profit": 1339900000.0, "net_income": 759900000.0, "operating_cash_flow": 532200000.0, "operating_income": 47200000.0, "revenue": 2583200000.0, "stockholders_equity": 7453600000.0, "total_assets": 10576500000.0, "total_liabilities": 3122900000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5186977392381542, "leverage": 0.4189787485242031, "net_margin": 0.29417002167853823, "operating_margin": 0.018271910808299784, "revenue_growth_yoy": 0.0065069160335086695, "roa_avg2y": 0.07621636259691283, "roa_period_end": 0.07184796482768402, "roe_avg2y": 0.1083798643647177, "roe_period_end": 0.10195073521519803 } }, { "accn": "0000012208-26-000010", "filed": "2026-02-13", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 203600000.0, "capex": 165600000.0, "cash": 488100000.0, "cost_of_revenue": 1187600000.0, "eps_diluted": -65.36, "free_cash_flow": 289600000.0, "gross_profit": 1378900000.0, "net_income": -1844200000.0, "operating_cash_flow": 455200000.0, "operating_income": 269000000.0, "revenue": 2566500000.0, "stockholders_equity": 6569300000.0, "total_assets": 9364100000.0, "total_liabilities": 2794800000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5372686538086888, "leverage": 0.42543345561932017, "net_margin": -0.7185661406584843, "operating_margin": 0.10481200077927139, "revenue_growth_yoy": -0.03919586702605571, "roa_avg2y": -0.1702610879279146, "roa_period_end": -0.19694364647964033, "roe_avg2y": -0.24090656738839358, "roe_period_end": -0.2807300625637435 } }, { "accn": "0000012208-26-000010", "filed": "2026-02-13", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 428700000.0, "capex": 156700000.0, "cash": 403800000.0, "cost_of_revenue": 1244300000.0, "eps_diluted": -21.82, "free_cash_flow": 218200000.0, "gross_profit": 1426900000.0, "net_income": -637300000.0, "operating_cash_flow": 374900000.0, "operating_income": 337800000.0, "revenue": 2671200000.0, "stockholders_equity": 8741200000.0, "total_assets": 12299100000.0, "total_liabilities": 3557900000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5341793950284517, "leverage": 0.40702649521804785, "net_margin": -0.23858191075172208, "operating_margin": 0.12646001796945194, "revenue_growth_yoy": -0.04674898294197416, "roa_avg2y": -0.0494016340445086, "roa_period_end": -0.05181679960322301, "roe_avg2y": -0.06943627290754179, "roe_period_end": -0.07290760993913879 } }, { "accn": "0000012208-26-000010", "filed": "2026-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 215700000.0, "capex": 112800000.0, "cash": 434200000.0, "cost_of_revenue": 1234900000.0, "eps_diluted": -121.79, "free_cash_flow": 81600000.0, "gross_profit": 1567300000.0, "net_income": -3627500000.0, "operating_cash_flow": 194400000.0, "operating_income": 482600000.0, "revenue": 2802200000.0, "stockholders_equity": 9615200000.0, "total_assets": 13501666000.0, "total_liabilities": 3886414000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5593105417172222, "leverage": 0.40419481654047756, "net_margin": -1.294518592534437, "operating_margin": 0.17222182570837197, "roa_avg2y": -0.2317812953229474, "roa_period_end": -0.26867054776795696, "roe_avg2y": -0.31136804518377365, "roe_period_end": -0.3772672435310758 } }, { "accn": "0000012208-25-000007", "filed": "2025-02-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 49998000.0, "capex": 133746000.0, "cash": 470783000.0, "eps_diluted": 140.83, "free_cash_flow": 535718000.0, "gross_profit": 1638096000.0, "net_income": 4254257000.0, "operating_cash_flow": 669464000.0, "operating_income": 500336000.0, "stockholders_equity": 13685200000.0, "total_assets": 17799393000.0, "total_liabilities": 4114157000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3006281968842253, "roa_avg2y": 0.2765017209957451, "roa_period_end": 0.23901135280287367, "roe_avg2y": 0.3609143068214919, "roe_period_end": 0.3108655335691112 } }, { "accn": "0000012208-24-000013", "filed": "2024-02-16", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 100004000.0, "capex": 108564000.0, "cash": 662205000.0, "eps_diluted": 126.47, "free_cash_flow": 476408000.0, "gross_profit": 1437887000.0, "net_income": 3814229000.0, "operating_cash_flow": 584972000.0, "operating_income": 421326000.0, "stockholders_equity": 9889687000.0, "total_assets": 12972618000.0, "total_liabilities": 3092678000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3127174803408844, "roa_avg2y": 0.36358060016461186, "roa_period_end": 0.29402153058079716, "roe_avg2y": 0.4875495389424709, "roe_period_end": 0.38567742336031463 } }, { "accn": "0000012208-23-000031", "filed": "2023-02-17", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 28000000.0, "capex": 98532000.0, "cash": 660672000.0, "cost_of_revenue": 1054704000.0, "eps_diluted": 58.27, "free_cash_flow": 359365000.0, "gross_profit": 1256996000.0, "net_income": 1758675000.0, "operating_cash_flow": 457897000.0, "operating_income": 229661000.0, "revenue": 2311700000.0, "stockholders_equity": 5756842000.0, "total_assets": 8008859000.0, "total_liabilities": 2253802000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5437539473115024, "leverage": 0.39149971460047017, "net_margin": 0.7607712938530085, "operating_margin": 0.09934723363758273, "revenue_growth_yoy": 0.009740543373809732, "roa_avg2y": 0.25825028283925455, "roa_period_end": 0.21959120518915365, "roe_avg2y": 0.359751228703839, "roe_period_end": 0.30549301161991244 } }, { "accn": "0000012208-22-000011", "filed": "2022-02-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 48912000.0, "capex": 129825000.0, "cash": 431526000.0, "cost_of_revenue": 1066249000.0, "eps_diluted": 12.1, "free_cash_flow": 155669000.0, "gross_profit": 1223151000.0, "net_income": 365614000.0, "operating_cash_flow": 285494000.0, "operating_income": -103341000.0, "revenue": 2289400000.0, "stockholders_equity": 4020331000.0, "total_assets": 5611068000.0, "total_liabilities": 1590737000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5342670568707958, "leverage": 0.39567314233579276, "net_margin": 0.15969861098977897, "operating_margin": -0.04513890102210186, "revenue_growth_yoy": 0.05980927691880381, "roa_avg2y": 0.07398038057158582, "roa_period_end": 0.0651594313239476, "roe_avg2y": 0.10520386712995647, "roe_period_end": 0.09094126826870723 } }, { "accn": "0000012208-21-000012", "filed": "2021-02-16", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2920000.0, "capex": 111332000.0, "cash": 383824000.0, "cost_of_revenue": 972497000.0, "eps_diluted": 4.07, "free_cash_flow": -7195000.0, "gross_profit": 1187703000.0, "net_income": 122249000.0, "operating_cash_flow": 104137000.0, "operating_income": 119250000.0, "revenue": 2160200000.0, "stockholders_equity": 2930250000.0, "total_assets": 4273012000.0, "total_liabilities": 1342762000.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5498115915193038, "leverage": 0.45824144697551406, "net_margin": 0.05659151930376817, "operating_margin": 0.055203221923895936, "revenue_growth_yoy": 0.04448312542307321, "roa_avg2y": 0.030097558741805887, "roa_period_end": 0.028609561592618977, "roe_avg2y": 0.044378254658847316, "roe_period_end": 0.04171964849415579 } }, { "accn": "0000012208-20-000012", "filed": "2020-03-02", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 141436000.0, "cash": 456264000.0, "cost_of_revenue": 929772000.0, "eps_diluted": 0.88, "free_cash_flow": 74630000.0, "gross_profit": 1138428000.0, "net_income": 26000000.0, "operating_cash_flow": 216066000.0, "operating_income": 55718000.0, "revenue": 2068200000.0, "stockholders_equity": 2579160000.0, "total_assets": 3850504000.0, "total_liabilities": 1271344000.0 }, "period_end": "2016-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.550443864229765, "leverage": 0.4929294809162673, "net_margin": 0.012571318054346773, "operating_margin": 0.02694033459046514, "roa_period_end": 0.006752362807570126, "roe_period_end": 0.010080801501263977 } } ], "latest_filing": { "accn": "0000012208-26-000010", "filed": "2026-02-13", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3826", "sic_description": "Laboratory Analytical Instruments", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000012208.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000012208.json" }, "ticker": "BIO" }